Company profile

Amniotics company profile

Amniotics is a biopharma company focusing on mesenchymal stem cells (MSC) from amniotic fluid. The company was born out of the discovery of a novel source of stem cells in full-term amniotic fluid. Based on a decade of research at the internationally recognized Lund University Stem Cell Centre and the University Hospital of Lund, the company is pioneering the harvesting and propagation of tissue specific neonatal quality mesenchymal stem cells (MSC). These stem cells have unique properties for applications in regenerative medicine. Amniotics has also an, by Läkemedelsverket (MPA in Sweden), approved GMP (Good Manufacturing Practice) manufacturing facility to produce..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2015-01-01

Headquarters

Headquarters
Byumba, Northern Province, Rwanda
Postal code
223 63
Country code
RW
Continent
Africa

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
2
Total equity funding
$2.1M
Last funding
Series Unknown / 2021-01-12
Last equity funding
Series Unknown
Investors
2
Founders
1
Articles
20
Exited on
2021-07-06

Founders and investors

Founders

Marcus Larsson

Investors

Almi InvestLU Innovation

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.